High Costs Continue to Limit Access to Life-Saving Genetic Therapies

Publisher name

CBS News, 60 Minutes

The article examines how approved genetic therapies can offer curative outcomes for rare and severe diseases while carrying price tags that reach several million dollars per dose. It highlights the structural drivers behind these costs, including complex manufacturing, small patient populations, and reimbursement challenges, raising questions about long-term sustainability and equitable access within healthcare systems.

👉 Read the full article: Genetic therapies can save lives but many cost millions per dose

Disclaimer

Images are illustrative only. This content does not constitute medical advice. SSCTR is not responsible for clinical or regulatory decisions. The content is provided for informational and educational purposes only.